# Ondansetron in Treatment Resistant Obsessive Compulsive Disorder (OCD)

> **NCT00796497** · PHASE4 · COMPLETED · sponsor: **Institute of Neuroscience, Florence, Italy** · enrollment: 14 (actual)

## Conditions studied

- Obsessive Compulsive Disorder

## Interventions

- **DRUG:** ondansetron

## Key facts

- **NCT ID:** NCT00796497
- **Lead sponsor:** Institute of Neuroscience, Florence, Italy
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2008-11
- **Final completion:** 2008-12
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2011-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00796497

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00796497, "Ondansetron in Treatment Resistant Obsessive Compulsive Disorder (OCD)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00796497. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*